A study on DNA hydroxymethylation in Kaposi sarcoma and cutaneous angiosarcoma
- 11 April 2020
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 34 (12), E785-E787
- https://doi.org/10.1111/jdv.16444
Abstract
Click on the article title to read more.Keywords
This publication has 9 references indexed in Scilit:
- The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancerBreast Cancer Research and Treatment, 2019
- Decreased 5‐hydroxymethylcytosine immunoreactivity in primary Merkel cell carcinoma is a strong predictor for disease‐specific deathBritish Journal of Dermatology, 2019
- Cutaneous Angiosarcoma: The Possibility of New Treatment Options Especially for Patients with Large Primary TumorFrontiers in Oncology, 2018
- DNA methylation/hydroxymethylation in melanomaOncotarget, 2017
- Decreased 5-hydroxymethylcytosine levels correlate with cancer progression and poor survival: a systematic review and meta-analysisOncotarget, 2016
- Decreased expression of ten-eleven translocation 2 protein is associated with progressive disease and death in patients with mycosis fungoidesBritish Journal of Dermatology, 2015
- High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research, 2014
- Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanomaMelanoma Research, 2013
- Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of MelanomaCell, 2012